Astragaloside IV Alleviates Lupus Nephritis by Inhibiting Podocyte Ferroptosis via the PI3K/AKT/Nrf2 Pathway
Zhongfu Tang, Lili Cheng, Ming Li, Chuanbing Huang · 2026
Read Astragaloside IV Alleviates Lupus Nephritis by Inhibiting Podocyte Ferroptosis via the PI3K/AKT/Nrf2 Pathway by Zhongfu Tang, Lili Cheng, Ming Li, Chuanbing Huang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13225287.txt.
Description
Zhongfu Tang and colleagues evaluate a 2026 study of astragaloside IV, the main active compound of the traditional herb Astragalus, against lupus nephritis. In this kidney complication of lupus, filtering cells called podocytes can die through ferroptosis, an iron-driven death pathway. Lupus-prone mice received the compound, and a cell model of podocyte injury tested the mechanism directly.
Kidney tissue in treated mice showed less damage, fewer deposits, and lower protein leakage into urine. In injured cells, the compound raised protective factors tied to the PI3K/AKT/Nrf2 pathway and restored several anti-ferroptosis defences. Rescue experiments, which block the pathway again, supported that route as the means of protection, though the work remains preclinical.
Catalog record
| CREATOR | Zhongfu Tang, Lili Cheng, Ming Li, Chuanbing Huang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 67 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |